Metabolic Weekly
Research

GLP-1 Drugs and Seasonal Weight Gain: What the Research Actually Shows

Do GLP-1 medications like Ozempic and Zepbound protect against seasonal weight gain? Here is what two years of trial data says, and practical strategies to protect your progress year-round.

Maren Thiessen

Maren Thiessen

Clinical Health Writer

Dr. Yara Benedetti

Medically Reviewed by

Dr. Yara Benedetti

Endocrinologist, Mayo Clinic

Published March 5, 2026 · 8 min read

Start GLP-1 Treatment Before Spring

Patients who start in winter are at full therapeutic dose by spring — positioned for the best results. Remedy Meds offers physician-supervised programs with transparent pricing.

See If You Qualify →

Every summer, the same thing happens: people spend months losing weight, only to regain much of it when routines fall apart in December. With GLP-1 medications, the dynamics are different — but the seasonal challenge is not.

Here is what the research says about GLP-1 medications and seasonal weight patterns, and what you can do to protect your progress through the harder months.

Do GLP-1 Drugs Prevent Seasonal Weight Gain?

The short answer: yes, significantly. But the mechanism is not magic — it is pharmacology.

GLP-1 receptor agonists work partly by slowing gastric emptying and signaling satiety to the brain. Both effects persist regardless of season. The holiday food environment — calorie-dense dishes, larger portions, more frequent social eating — still exists. What changes is your body’s response to it.

Clinical trial data from the STEP 5 trial (two-year follow-up on semaglutide 2.4 mg) showed continued weight maintenance without the typical regain pattern seen in behavioral-only interventions. Seasonal variation was minimal compared to placebo groups, where the classic holiday weight gain pattern was visible in the data.

Tirzepatide data from the SURMOUNT trials showed similar resilience to seasonal variation at stable doses. The dual GLP-1/GIP mechanism appears particularly effective at dampening the appetite surge that typically accompanies cold weather and reduced daylight.

Why Seasonal Weight Gain Happens (Even on GLP-1s)

Understanding the biological drivers of seasonal weight gain helps you counter them specifically.

Light and serotonin: Reduced daylight in fall and winter lowers serotonin production. Serotonin and appetite are tightly linked — lower serotonin often means increased cravings, particularly for carbohydrates and calorie-dense foods. GLP-1s blunt this partially but do not eliminate it entirely.

Physical activity decline: Most people move less in cold months. GLP-1 medications suppress appetite but do not directly affect exercise motivation. A 20% drop in physical activity — common from October to February — meaningfully affects energy balance even on medication.

Dose disruption: Travel, schedule changes, and missed doses around holidays can disrupt the steady-state blood levels that make GLP-1 medications most effective. Missing a single weekly injection at maintenance dose can noticeably increase appetite in the days before the next dose.

Alcohol: GLP-1 users often report reduced desire to drink, which supports weight loss. Many patients find this benefit weakens in social holiday settings. Alcohol adds calories and lowers dietary inhibition simultaneously.

The Data on Weight Maintenance During Discontinuation

This matters because some patients reduce their dose or pause treatment during the holidays due to cost or travel logistics. A major BMJ meta-analysis published in January 2026 quantified what that looks like: average regain of 1.8 pounds per month after stopping semaglutide or tirzepatide. Return to baseline weight projected at approximately 18 months.

A two-week dose pause around the holidays typically produces 3–4 pounds of regain for most patients — meaningful but recoverable. The more important risk is that temporary pauses sometimes become permanent discontinuations when patients feel demoralized by regain.

If you need to pause for travel or cost reasons, plan your restart date before you stop. Having the next shipment already scheduled significantly improves follow-through.

Practical Strategies for Seasonal Protection

Do not skip the injection around holidays. This is the single most impactful thing you can do. Plan injection timing around travel. Most GLP-1 medications are stable at room temperature for short periods — check your specific medication’s storage requirements and plan accordingly.

Shift your injection day if needed. Weekly semaglutide and tirzepatide can be shifted by a day or two without meaningfully affecting efficacy. If your usual injection day falls on Thanksgiving or Christmas, move it two days earlier that week.

Protein first, every time. The satiety mechanism of GLP-1 medications is amplified when you lead meals with protein. At holiday meals, put turkey, salmon, or other protein on the plate before anything else. This is not deprivation — it is sequencing that works with your medication.

Treat exercise as non-negotiable infrastructure. Not weight loss — maintenance. Even 20 minutes of walking daily prevents the metabolic deceleration that compounds seasonal caloric increase. Cold weather gear is a one-time purchase; the habit payoff is year-round.

Alcohol strategy: GLP-1 medications do not mix well with high-sugar cocktails physiologically — many patients report increased nausea. Dry wine and spirits tend to be better tolerated. Set a soft limit before social events, not in the moment.

The Spring Rebound Pattern

Patients who maintain their GLP-1 dose through winter consistently report a “spring acceleration” effect: when warmer weather and more activity return in March and April, weight loss often resumes at a faster rate than before the winter plateau. This is not the medication working harder — it is the synergy between the medication and naturally increasing physical activity.

This pattern is encouraging because it means a winter plateau is not a failure. It is a maintenance phase that sets up accelerated progress when conditions improve. The patients who capitalize on this are the ones who stayed on their medication through the harder months.

If You Are Considering Starting This Season

Starting GLP-1 therapy in fall or winter is not a bad time. The titration phase (first 8–12 weeks) overlaps with the period when seasonal weight gain typically happens — and even at sub-therapeutic doses, many patients notice meaningful appetite suppression that prevents the usual holiday accumulation.

By spring, a patient who started in October will be at full therapeutic dose and positioned for the spring rebound described above.

Remedy Meds offers medically supervised semaglutide programs with physician oversight, flexible scheduling, and transparent pricing. It is worth reviewing if you are considering starting treatment. Learn more at remedymeds.co.


Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any medication. Last updated: March 2026.

Ready to Start Your GLP-1 Journey?

Connect with a licensed provider who can prescribe compounded semaglutide — starting at a fraction of brand-name cost.

Check Your Eligibility →

*Affiliate link. We may earn a commission at no extra cost to you.

Maren Thiessen

Maren Thiessen

Clinical Health Writer

Health journalist covering GLP-1 medications, metabolic health, and the telehealth industry. All articles are fact-checked and medically reviewed.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult with a qualified healthcare provider before starting any medication. Last updated: March 5, 2026.